Ravena Maya Cardoso da Silva

Ravena Maya Cardoso da Silva

Auto-generated profile, based on publicly available information

Ravena Maya Cardoso da Silva

Faculdade de Medicina da Universidade Federal do Rio Grande do Sul (UFRGS), Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
IBIgor Gorski Benedetto
Igor Gorski Benedetto
RSRavena Maya Cardoso da Silva
Ravena Maya Cardoso da Silva
GHGuilherme Moreira Hetzel
Guilherme Moreira Hetzel
GVGabriel da Silva Viana
Gabriel da Silva Viana
AGAmanda Reis Guimarães
Amanda Reis Guimarães
DBDanilo Cortozi Berton
Danilo Cortozi Berton
Objective: To investigate the impact of impaired pulmonary function on patient-centered outcomes after hospital discharge due to severe COVID-19 in patients without preexisting respiratory disease. Methods: This is an ongoing prospective cohort study evaluating patients (> 18 years of age) 2-6 months after hospital discharge due to severe COVID-19. Respiratory symptoms, health-related quality of life, lung function, and the six-minute walk test were assessed. A restrictive ventilatory defect was defined as TLC below the lower limit of normal, as assessed by plethysmography. Chest CT scans performed during hospitalization were scored for the presence and extent of parenchymal abnormalities. Results: At a mean follow-up of 17.2 ± 5.9 weeks after the diagnosis of COVID-19, 120 patients were assessed. Of those, 23 (19.2%) reported preexisting chronic respiratory diseases and presented with worse lung function and exertional dyspnea at the follow-up visit in comparison with their counterparts. When we excluded the 23 patients with preexisting respiratory disease plus another 2 patients without lung volume measurements, a restrictive ventilatory defect was observed in 42/95 patients (44%). This subgroup of patients (52.4% of whom were male; mean age, 53.9 ± 11.3 years) showed reduced resting gas exchange efficiency (DLCO), increased daily-life dyspnea, increased exertional dyspnea and oxygen desaturation, and reduced health-related quality of life in comparison with those without reduced TLC (50.9% of whom were male; mean age, 58.4 ± 11.3 years). Intensive care need and higher chest CT scores were associated with a subsequent restrictive ventilatory defect. Conclusions: The presence of a restrictive ventilatory defect approximately 4 months after severe COVID-19 in patients without prior respiratory comorbidities implies worse clinical outcomes.

1 January 2025 in Radiologia Brasileira
Verified
Journal Article
Open access
LFLuciano Folador
Luciano Folador
VBVicente Bohrer Brentano
Vicente Bohrer Brentano
RSRavena Maya Cardoso da Silva
Ravena Maya Cardoso da Silva
IBIgor Gorski Benedetto
Igor Gorski Benedetto
MGMarcelo Basso Gazzana
Marcelo Basso Gazzana
TGTiago Severo Garcia
Tiago Severo Garcia
Objective: To assess the prevalence and type of residual lung abnormalities on chest computed tomography (CT) and pulmonary function testing (PFT) variables in patients with respiratory symptoms related to post-COVID-19 condition at 12 months of follow-up, and to analyze associations between CT findings and PFT parameters. Materials and Methods: The CT findings were evaluated by two radiologists, who calculated semiquantitative CT scores. The PFTs included spirometry, plethysmography, and the diffusing capacity of the lung for carbon monoxide. Results: Thirty-seven patients were included in the study. On CT scans of the chest acquired at 12 months of follow-up, 78.3% of the patients exhibited residual abnormalities, including reticular opacities, in 75.7%; traction bronchiectasis/bronchiolectasis, in 43.2%; and fibrosis-like findings, in 43.2%. The mean overall CT score was 9.30 ± 2.59. Patients with fibrosis-like findings had significantly lower total lung capacity (68.6% vs. 80.6% of the predicted value; p = 0.018). A moderate negative correlation was found between the overall CT score and total lung capacity (rs = −0.49; p = 0.003). Conclusion: It seems that a significant proportion of patients with respiratory symptoms related to post–COVID-19 condition demonstrate residual lung abnormalities on chest CT at 12 months of follow-up, with a substantial prevalence of fibrosis-like findings. Such abnormalities are associated with restrictive lung disease.